TipRanks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
GLUE
Monte Rosa Therapeutics
RESEARCH TOOLSreports
Want to see GLUE full AI Analyst Report?

Monte Rosa Therapeutics (GLUE) Balance Sheet

398 Followers

Monte Rosa Therapeutics Balance Sheet

Monte Rosa Therapeutics's total assets for Q2 2026 were $696.08M, a decrease of -5.48% from the previous quarter. GLUE total liabilities were $211.03M for the fiscal quarter, a -1.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 448.66M$ 438.73M$ 303.75M$ 342.39M$ 366.33M
Total Liabilities
$ 215.60M$ 215.80M$ 124.50M$ 70.98M$ 18.81M
Total Equity Gross Minority
$ 233.06M$ 222.94M$ 179.25M$ 271.41M$ 347.51M
Other Metrics
Currency in USD

Monte Rosa Therapeutics Debt to Assets